Reducible siRNA dimeric conjugates for efficient cellular uptake and gene silencing

Bioconjugate Chemistry

Volumn 22, Issue 2, 2011, Pages 299-306

  Chung, Hyun Jung ^a   Hong, Cheol Am ^a   Lee, Soo Hyeon ^a   Jo, Sung Duk ^a   Park, Tae Gwan ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL ENGINEERING; COVALENT BONDS; DIMERS; EFFICIENCY; ENDOTHELIAL CELLS; GENE THERAPY; GENETIC ENGINEERING; MOLECULAR BIOLOGY; POLYETHYLENE GLYCOLS; SULFUR COMPOUNDS;

CATIONIC POLYMERS; CELLULAR GENES; CELLULAR UPTAKE; DISULPHIDE BONDS; GENE SILENCING; GREEN FLUORESCENT PROTEIN; INTRACELLULAR DELIVERY; LINEAR POLYETHYLENIMINE; SYNTHESISED; VASCULAR ENDOTHELIAL GROWTH FACTOR;

RNA;

DIMER; GREEN FLUORESCENT PROTEIN; LINEAR POLYETHYLENIMINE; MACROGOL; MONOMER; POLYMER; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CELL LINE; CELL TRANSPORT; CHEMICAL MODIFICATION; CONJUGATION; CONTROLLED STUDY; DIMERIZATION; GEL; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY;

EID: 79951704506     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc100438m     Document Type: Article

References (28)

1. Meister, G. and Tuschl, T. (2004) Mechanisms of gene silencing by double-stranded RNA Nature 43, 343-349
2. Carthew, R. W. and Sontheimer, E. J. (2009) Origins and mechanisms of miRNAs and siRNAs Cell 136, 642-655
3. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 411, 494-498
4. de Fougerolles, A., Vornlocher, H., Maraganore, J., and Lieberman, J. (2007) Interfering with disease: a progress report on siRNA-based therapeutics Nat. Rev. Drug Discovery 6, 443-453
5. Dykxhoorn, D. M. and Lieberman, J. (2006) Knocking down disease with siRNAs Cell 126, 231-235
6. Oh, Y. and Park, T. G. (2009) siRNA delivery systems for cancer treatment Adv. Drug Delivery Rev. 61, 850-862
7. Park, T. G., Jeong, J. H., and Kim, S. W. (2006) Current status of polymeric gene delivery systems Adv. Drug Delivery Rev. 58, 467-486
8. Kim, W. J. and Kim, S. W. (2009) Efficient siRNA delivery with non-viral polymeric vehicles Pharm. Res. 26, 657-666
9. Eguchi, A., Meade, B. R., Chang, Y., Fredrickson, C. T., Willert, K., Puri, N., and Dowdy, S. F. (2009) Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein Nat. Biotechnol. 27, 567-572
10. Schroeder, A., Levins, C. G., Cortez, C., Langer, R., and Anderson, D. G. (2009) Lipid-based nanotherapeutics for siRNA delivery J. Int. Med. 267, 9-21
11. Dalby, B., Cates, S., Harris, A., Ohki, E. C., Tilkins, M. L., Price, P. J., and Ciccarone, V. C. (2004) Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications Methods 33, 95-103
12. Ifediba, M. A., Medarova, Z., Ng, S., Yang, J., and Moore, A. (2010) siRNA delivery to CNS cells using a membrane translocation peptide Bioconjugate Chem. 21, 803-806
13. Höbel, S., Koburger, I., John, M., Czubayko, F., Hadwiger, P., Vornlocher, H., and Aigner, A. (2010) Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab J. Gene Med. 12, 287-300
14. Mok, H. and Park, T. G. (2008) Self-crosslinked and reducible fusogenic peptides for intracellular delivery of siRNA Biopolymers 89, 881-888
15. Breunig, M., Hozsa, C., Lungwitz, U., Watanabe, K., Umeda, I., Kato, H., and Goepferich, A. (2008) Mechanistic investigation of poly(ethylene imine)-based siRNA delivery: disulfide bonds boost intracellular release of the cargo J. Controlled Release 130, 57-63
16. Salcher, E. E. and Wagner, E. (2010) Chemically programmed polymers for targeted DNA and siRNA transfection Top. Curr. Chem. 1-24
17. Kim, S. H., Jeong, J. H., Lee, S. H., Kim, S. W., and Park, T. G. (2006) PEG conjugated VEGF siRNA for anti-angiogenic gene therapy J. Controlled Release 116, 123-129
18. Kim, S. H., Jeong, J. H., Lee, S. H., Kim, S. W., and Park, T. G. (2008) LHRH receptor-mediated delivery of siRNA using polyelectrolyte complex micelles self-assembled from siRNA-PEG-LHRH conjugate and PEI Bioconjugate Chem. 19, 2156-2162
19. Lee, H., Mok, H., Lee, S., Oh, Y., and Park, T. G. (2007) Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels J. Controlled Release 119, 245-252
20. Bolcato-Bellemin, A., Bonnet, M., Creusat, G., Erbacher, P., and Behr, J. (2007) Sticky overhangs enhance siRNA-mediated gene silencing Proc. Natl. Acad. Sci. U.S.A. 104, 16050-16055
21. Mok, H., Lee, S. H., Park, J. W., and Park, T. G. (2010) Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing Nat. Mater. 9, 272-278
22. Lee, S., Huh, M. S., Lee, S., Lee, S. J., Chung, H., Park, J. H., Oh, Y., Choi, K., Kim, K., and Kwon, I. C. (2010) Stability and cellular uptake of polymerized siRNA (poly-siRNA)/polyethylenimine (PEI) complexes for efficient gene silencing J. Controlled Release 141, 3339-346
23. Chang, C. I., Kang, H. S., Ban, C., Kim, S., and Lee, D. (2009) Dual-target gene silencing by using long, synthetic siRNA duplexes without triggering antiviral responses Mol. Cells 27, 689-695
24. Chang, C. I., Yoo, J. W., Hong, S. W., Lee, S. E., Kang, H. S., Sun, X., Rogoff, H. A., Ban, C., Kim, S., J Li, C., and Lee, D. (2009) Asymmetric shorter-duplex siRNA structures trigger efficient gene silencing with reduced nonspecific effects Mol. Ther. 17, 725-732
25. Prabha, S., Zhou, W., Panyam, J., and Labhasetwar, V. (2002) Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles Int. J. Pharm. 244, 105-115
26. Korpisalo, P., Karvinen, H., Rissanen, T. T., Kilpijoki, J., Marjomäki, V., Baluk, P., McDonald, D. M., Cao, Y., Eriksson, U., Alitalo, K., and Ylä-Herttuala, S. (2008) Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogenic vessels Circ. Res. 103, 1092-1099
27. Kim, S. H., Jeong, J. H., Lee, S. H., Kim, S. W., and Park, T. G. (2008) Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer J. Controlled Release 129, 107-116
28. Jung, S., Lee, S. H., Mok, H., Chung, H. J., and Park, T. G. (2010) Gene silencing efficiency of siRNA-PEG conjugates: effect of PEGylation site and PEG molecular weight J. Controlled Release 144, 306-313